55
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Impact of the Background Regimen on Virologic Response to Etravirine: Pooled 48-Week Analysis of DUET-1 and -2

, , , , , & show all
Pages 175-185 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Benoit Trottier, Chrissi Galanakis, Danièle Longpré, Harold Dion, Sylvie Vézina, Stéphane Lavoie, Michel Boissonnault, Cecilia Costiniuk, Mohammad-Ali Jenabian, Nimâ Machouf & Réjean Thomas. (2015) Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054). HIV Clinical Trials 16:3, pages 111-116.
Read now
Jaime Robertson & Judith Feinberg. (2012) Darunavir: a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection. Expert Opinion on Pharmacotherapy 13:9, pages 1363-1375.
Read now

Articles from other publishers (7)

Joshua P. Havens, Anthony T. Podany, Kimberly K. Scarsi & Courtney V. Fletcher. (2019) Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review. Clinical Pharmacokinetics 59:2, pages 137-154.
Crossref
Katherine A. Lyseng-Williamson & Jamie D. Croxtall. (2013) Etravirine: a guide to its use in treatment-experienced adults with HIV-1 infection. Drugs & Therapy Perspectives 30:1, pages 1-9.
Crossref
Monika Schöller‐Gyüre, Thomas N. Kakuda, James Witek, Sophie H. Akuma, Goedele De Smedt, Kurt Spittaels, Veerle Vyncke & Richard M.W. Hoetelmans. (2013) Steady‐State Pharmacokinetics of Etravirine and Lopinavir/Ritonavir Melt Extrusion Formulation, Alone and in Combination, in Healthy HIV‐Negative Volunteers. The Journal of Clinical Pharmacology 53:2, pages 202-210.
Crossref
Eugene L. Asahchop, Mark A. Wainberg, Richard D. Sloan & Cécile L. Tremblay. (2012) Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy 56:10, pages 5000-5008.
Crossref
Jamie D. Croxtall. (2012) Etravirine. Drugs 72:6, pages 847-869.
Crossref
Mark A. Wainberg. (2012) The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance. Scientifica 2012, pages 1-28.
Crossref
Arkaitz Imaz, Josep M Llibre, Esteban Ribera, Bonaventura Clotet & Daniel Podzamczer. (2011) The Role of Inactive Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Salvage Therapy for Drug-Resistant HIV-1 Infection in the Era of New Classes and New Generation Antiretrovirals. JAIDS Journal of Acquired Immune Deficiency Syndromes 58:2, pages e46-e48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.